Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents

BACKGROUND: Gadolinium-based contrast agent (GBCA)-enhanced magnetic resonance imaging (MRI) scans often must be used repeatedly in pediatric oncologic patients. Although GBCAs are usually well tolerated, severe and life-threatening allergic reactions might occur, which can result in overly cautions...

Descripción completa

Detalles Bibliográficos
Autores principales: Hojreh, Azadeh, Peyrl, Andreas, Bundalo, Aleksandra, Szepfalusi, Zsolt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122741/
https://www.ncbi.nlm.nih.gov/pubmed/32243440
http://dx.doi.org/10.1371/journal.pone.0230781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122741/
https://www.ncbi.nlm.nih.gov/pubmed/32243440
http://dx.doi.org/10.1371/journal.pone.0230781

Ejemplares similares